Danimer Scientific (DNMR) Stock Price, News & Analysis

Company Overview

Danimer Scientific, Inc., a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative under the Nodax brand name for applications in films, straws, cutlery, food containers, and others; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company products are used in various applications, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.

Key Stats

• Today's Range: $0.22 to $0.39
• 50-Day Range: $0.21 to $1.85
• 52-Week Range: $0.33 to $47.60
• Volume: 13,357 shs
• Average Volume: 39,988 shs
• Market Capitalization: $694,600.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $13.83
• Consensus Rating: Reduce

Danimer Scientific Stock Analysis - MarketRank™

Danimer Scientific scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.8 / 5
• Analyst Rating: Reduce

Consensus Rating

Danimer Scientific has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Danimer Scientific has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Danimer Scientific is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Danimer Scientific is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Danimer Scientific has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for DNMR.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Danimer Scientific does not currently pay a dividend.

Dividend Growth

Danimer Scientific does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for DNMR.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Danimer Scientific this week, compared to 1 article on an average week.

Search Interest

Only 6 people have searched for DNMR on MarketBeat in the last 30 days. This is a decrease of -14% compared to the previous 30 days.

MarketBeat Follows

3 people have added Danimer Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Danimer Scientific insiders have not sold or bought any company stock.

Percentage Held by Insiders

16.60% of the stock of Danimer Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 33.84% of the stock of Danimer Scientific is held by institutions.

DNMR Stock Analysis - Frequently Asked Questions

How have DNMR shares performed this year?

Danimer Scientific's stock was trading at $2.10 at the beginning of 2025. Since then, DNMR stock has decreased by 89.0% and is now trading at $0.23.
View the best growth stocks for 2025 here.

When did Danimer Scientific's stock split?

Shares of Danimer Scientific reverse split on Wednesday, November 13th 2024. The 1-40 reverse split was announced on Friday, November 1st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, November 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Who are Danimer Scientific's major shareholders?

Danimer Scientific's top institutional investors include Jefferies Financial Group Inc., Group One Trading LLC, Citadel Advisors LLC and Concourse Financial Group Securities Inc.. Insiders that own company stock include Stuart W Pratt and Scott Tuten.
View institutional ownership trends.

How do I buy shares of Danimer Scientific?

Shares of DNMR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Danimer Scientific own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Danimer Scientific investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), PayPal (PYPL), JPMorgan Chase & Co. (JPM) and

Company Calendar

• Today: 3/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Industrials
• Industry: Plastics materials & resins
• Sub-Industry: Chemicals
• Current Symbol: NYSE:DNMR
• CIK: 1779020
• Web: danimerscientific.com
• Phone: 229-243-7075
• Fax: N/A
• Employees: 280
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $13.83
• High Stock Price Target: $32.00
• Low Stock Price Target: $4.00
• Potential Upside/Downside: +5,914.5%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($33.78)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-155,470,000.00
• Net Margins: -297.10%
• Pretax Margin: -297.08%
• Return on Equity: -47.85%
• Return on Assets: -17.38%

Debt

• Debt-to-Equity Ratio: 1.80
• Current Ratio: 3.28
• Quick Ratio: 2.05

Sales & Book Value

• Annual Sales: $37.43 million
• Price / Sales: 0.02
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $108.14 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 3,020,000
• Free Float: 2,519,000
• Market Cap: $694,600.00
• Optionable: Optionable
• Beta: 1.49